This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, T
Right arrow Articles by Swain, J L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, T
Right arrow Articles by Swain, J L

 Previous Article  |  Next Article 

Mol Cell Biol. 1990 July; 10(7): 3709-3716

The c-myc proto-oncogene regulates cardiac development in transgenic mice.

T Jackson, M F Allard, C M Sreenan, L K Doss, S P Bishop and J L Swain

Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

ABSTRACT

During the maturation of the cardiac myocyte, a transition occurs from hyperplastic to hypertrophic growth. The factors that control this transition in the developing heart are unknown. Proto-oncogenes such as c-myc have been implicated in the regulation of cellular proliferation and differentiation, and in the heart the switch from myocyte proliferation to terminal differentiation is synchronous with a decrease in c-myc mRNA abundance. To determine whether c-myc can influence myocyte proliferation or differentiation, we examined the in vivo effect of increasing c-myc expression during embryogenesis and of preventing the decrease in c-myc mRNA expression that normally occurs during cardiac development. The model system used was a strain of transgenic mice exhibiting constitutive expression of c-myc mRNA in cardiac myocytes throughout development. In these transgenic mice, increased c-myc mRNA expression was found to be associated with both atrial and ventricular enlargement. This increase in cardiac mass was secondary to myocyte hyperplasia, with the transgenic hearts containing more than twice as many myocytes as did nontransgenic hearts. The results suggest that in the transgenic animals there is additional hyperplastic growth during fetal development. However, this additional proliferative growth is not reflected in abnormal myocyte maturation, as assessed by the expression of the cardiac and skeletal isoforms of alpha-actin. The results of this study indicate that constitutive expression of c-myc mRNA in the heart during development results in enhanced hyperplastic growth and suggest a regulatory role for this proto-oncogene in cardiac myogenesis.


Mol Cell Biol. 1990 July; 10(7): 3709-3716




This article has been cited by other articles:

  • Martinez-Fernandez, A., Nelson, T. J., Yamada, S., Reyes, S., Alekseev, A. E., Perez-Terzic, C., Ikeda, Y., Terzic, A. (2009). iPS Programmed Without c-MYC Yield Proficient Cardiogenesis for Functional Heart Chimerism. Circ. Res. 105: 648-656 [Abstract] [Full Text]  
  • Ahuja, P., Sdek, P., MacLellan, W. R. (2007). Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration. Physiol. Rev. 87: 521-544 [Abstract] [Full Text]  
  • Yutzey, K. E., Robbins, J. (2007). Principles of Genetic Murine Models for Cardiac Disease. Circulation 115: 792-799 [Abstract] [Full Text]  
  • Chen, H., Yong, W., Ren, S., Shen, W., He, Y., Cox, K. A., Zhu, W., Li, W., Soonpaa, M., Payne, R. M., Franco, D., Field, L. J., Rosen, V., Wang, Y., Shou, W. (2006). Overexpression of Bone Morphogenetic Protein 10 in Myocardium Disrupts Cardiac Postnatal Hypertrophic Growth. J. Biol. Chem. 281: 27481-27491 [Abstract] [Full Text]  
  • Engel, F. B., Schebesta, M., Duong, M. T., Lu, G., Ren, S., Madwed, J. B., Jiang, H., Wang, Y., Keating, M. T. (2005). p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 19: 1175-1187 [Abstract] [Full Text]  
  • Regula, K. M., Rzeszutek, M. J., Baetz, D., Seneviratne, C., Kirshenbaum, L. A. (2004). Therapeutic opportunities for cell cycle re-entry and cardiac regeneration. Cardiovasc Res 64: 395-401 [Abstract] [Full Text]  
  • Chaudhry, H. W., Dashoush, N. H., Tang, H., Zhang, L., Wang, X., Wu, E. X., Wolgemuth, D. J. (2004). Cyclin A2 Mediates Cardiomyocyte Mitosis in the Postmitotic Myocardium. J. Biol. Chem. 279: 35858-35866 [Abstract] [Full Text]  
  • Colomer, J. M., Terasawa, M., Means, A. R. (2004). Targeted Expression of Calmodulin Increases Ventricular Cardiomyocyte Proliferation and Deoxyribonucleic Acid Synthesis during Mouse Development. Endocrinology 145: 1356-1366 [Abstract] [Full Text]  
  • Muller, A. J., Baker, J. F., DuHadaway, J. B., Ge, K., Farmer, G., Donover, P. S., Meade, R., Reid, C., Grzanna, R., Roach, A. H., Shah, N., Soler, A. P., Prendergast, G. C. (2003). Targeted Disruption of the Murine Bin1/Amphiphysin II Gene Does Not Disable Endocytosis but Results in Embryonic Cardiomyopathy with Aberrant Myofibril Formation. Mol. Cell. Biol. 23: 4295-4306 [Abstract] [Full Text]  
  • Dorn, G. W. II, Robbins, J., Sugden, P. H. (2003). Phenotyping Hypertrophy: Eschew Obfuscation. Circ. Res. 92: 1171-1175 [Full Text]  
  • Wadhawan, R., Tseng, Y.-T., Stabila, J., McGonnigal, B., Sarkar, S., Padbury, J. (2003). Regulation of cardiac beta 1-adrenergic receptor transcription during the developmental transition. Am. J. Physiol. Heart Circ. Physiol. 284: H2146-H2152 [Abstract] [Full Text]  
  • Pasumarthi, K. B.S., Field, L. J. (2002). Cardiomyocyte Cell Cycle Regulation. Circ. Res. 90: 1044-1054 [Abstract] [Full Text]  
  • Meij, J. T. A., Sheikh, F., Jimenez, S. K., Nickerson, P. W., Kardami, E., Cattini, P. A. (2002). Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent. Am. J. Physiol. Heart Circ. Physiol. 282: H547-H555 [Abstract] [Full Text]  
  • El Oakley, R. M., Ooi, O. C., Bongso, A., Yacoub, M. H. (2001). Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart. Ann. Thorac. Surg. 71: 1724-1733 [Abstract] [Full Text]  
  • Schneider, M. D., MacLellan, W. R. (2001). Cyclin-Dependent Kinase-2 in the Birth and Death of Cardiac Muscle Cells. Circ. Res. 88: 367-369 [Full Text]  
  • Liao, H.-S., Kang, P. M., Nagashima, H., Yamasaki, N., Usheva, A., Ding, B., Lorell, B. H., Izumo, S. (2001). Cardiac-Specific Overexpression of Cyclin-Dependent Kinase 2 Increases Smaller Mononuclear Cardiomyocytes. Circ. Res. 88: 443-450 [Abstract] [Full Text]  
  • Sheikh, F., Sontag, D. P., Fandrich, R. R., Kardami, E., Cattini, P. A. (2001). Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. Am. J. Physiol. Heart Circ. Physiol. 280: H1039-H1050 [Abstract] [Full Text]  
  • Brewis, N., Ohst, K., Fields, K., Rapacciuolo, A., Chou, D., Bloor, C., Dillmann, W., Rockman, H., Walter, G. (2000). Dilated cardiomyopathy in transgenic mice expressing a mutant A subunit of protein phosphatase 2A. Am. J. Physiol. Heart Circ. Physiol. 279: H1307-H1318 [Abstract] [Full Text]  
  • Lanson, N. A. Jr, Egeland, D. B., Royals, B. A., Claycomb, W. C. (2000). The MRE11-NBS1-RAD50 pathway is perturbed in SV40 large T antigen-immortalized AT-1, AT-2 and HL-1 cardiomyocytes. Nucleic Acids Res 28: 2882-2892 [Abstract] [Full Text]  
  • Poolman, R. A., Li, J.-M., Durand, B., Brooks, G. (1999). Altered Expression of Cell Cycle Proteins and Prolonged Duration of Cardiac Myocyte Hyperplasia in p27KIP1 Knockout Mice. Circ. Res. 85: 117-127 [Abstract] [Full Text]  
  • Ogino, K., Cai, B., Gu, A., Kohmoto, T., Yamamoto, N., Burkhoff, D. (1999). Factors contributing to pressure overload-induced immediate early gene expression in adult rat hearts in vivo. Am. J. Physiol. Heart Circ. Physiol. 277: H380-H387 [Abstract] [Full Text]  
  • Wang, P. H., Almahfouz, A., Giorgino, F., McCowen, K. C., Smith, R. J. (1999). In Vivo Insulin Signaling in the Myocardium of Streptozotocin-Diabetic Rats: Opposite Effects of Diabetes on Insulin Stimulation of Glycogen Synthase and c-Fos. Endocrinology 140: 1141-1150 [Abstract] [Full Text]  
  • Hasenfuss, G. (1998). Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 39: 60-76 [Abstract] [Full Text]  
  • Chen, S., Su, J., Wu, K., Hu, W., Gardner, D. G., Chen, D. (1998). Early captopril treatment prevents hypertrophy-dependent gene expression in hearts of SHR. Am. J. Physiol. Regul. Integr. Comp. Physiol. 274: R1511-R1517 [Abstract] [Full Text]  
  • Hein, L., Stevens, M. E., Barsh, G. S., Pratt, R. E., Kobilka, B. K., Dzau, V. J. (1997). Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc. Natl. Acad. Sci. USA 94: 6391-6396 [Abstract] [Full Text]  
  • Julius, B. K., Spillmann, M., Vassalli, G., Villari, B., Eberli, F. R., Hess, O. M. (1997). Angina Pectoris in Patients With Aortic Stenosis and Normal Coronary Arteries: Mechanisms and Pathophysiological Concepts. Circulation 95: 892-898 [Abstract] [Full Text]  
  • Tanaka, N., Dalton, N., Mao, L., Rockman, H. A., Peterson, K. L., Gottshall, K. R., Hunter, J. J., Chien, K. R., Ross, J. (1996). Transthoracic Echocardiography in Models of Cardiac Disease in the Mouse. Circulation 94: 1109-1117 [Abstract] [Full Text]  
  • Chaillet, J R, Bader, D S, Leder, P (1995). Regulation of genomic imprinting by gametic and embryonic processes.. Genes Dev. 9: 1177-1187 [Abstract]  
  • Gardin, J. M., Siri, F. M., Kitsis, R. N., Edwards, J. G., Leinwand, L. A. (1995). Echocardiographic Assessment of Left Ventricular Mass and Systolic Function in Mice. Circ. Res. 76: 907-914 [Abstract] [Full Text]  
  • Moens, C., Stanton, B., Parada, L., Rossant, J (1993). Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus. Development 119: 485-499 [Abstract]  
  • Oh, H., Taffet, G. E., Youker, K. A., Entman, M. L., Overbeek, P. A., Michael, L. H., Schneider, M. D. (2001). Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc. Natl. Acad. Sci. USA 98: 10308-10313 [Abstract] [Full Text]  
  • Xiao, G., Mao, S., Baumgarten, G., Serrano, J., Jordan, M. C., Roos, K. P., Fishbein, M. C., MacLellan, W. R. (2001). Inducible Activation of c-Myc in Adult Myocardium In Vivo Provokes Cardiac Myocyte Hypertrophy and Reactivation of DNA Synthesis. Circ. Res. 89: 1122-1129 [Abstract] [Full Text]